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Comparison of chromosomal aberrations detected by
fluorescence in situ hybridization with clinical
parameters, DNA ploidy and Ki 67 expression in renal
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Summary To evaluate the significance of chromosomal aberrations in renal cell carcinoma, fluorescence in situ hybridization (FISH) was
used to determine its prevalence and correlation with clinical parameters of malignancy. In addition, correlation of chromosomal aberration
with Ki 67 expression was analysed. We performed FISH with chromosome-specific DNA probes, and the signal number of pericentromeric
sequences on chromosomes 3, 7, 9 and 17 was detected within interphase nuclei in touch preparations from tumourspecimen. The incidence
of loss of chromosome 3 was significantly higher than those of chromosomes 7, 9 and 17 (P < 0.001, P = 0.03 and P < 0.001 respectively).
Hyperdiploid aberration of chromosomes 3 and 17 was significantly correlated with tumour stage (P = 0.03, P = 0.02 respectively), whereas
hyperdiploid aberration of chromosome 9 was associated with nuclear grade (P= 0.04). Disomy of chromosome 7 was correlated with venous
involvement (P = 0.04). Ki 67 expression was significantly associated with hyperdiploid aberration of chromosome 17 (P= 0.01), but not with
aberration of chromosome 3. There was a significant relationship between hyperdiploid aberration of chromosome 7 and Ki 67 expression
(P = 0.01). In conclusions, gain of chromosome 17 may reflect tumour development, and aberration of chromosome 7 may affect metastatic
potential of malignancy, whereas loss of chromosome 3 may be associated with early stage of tumour development in renal cell carcinoma.
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Many authors have considered tumour stage to be a significant
prognostic factor for renal cell carcinoma (RCC) and nuclear
grade to be of variable significance, with the reproducibility of
grading being questioned (Arner et al, 1965; Syrjanen and Hjelt,
1978; Fuhrman et al, 1982; Lanigan, 1995). However, we assessed
whether or not other parameters have an ability to evaluate the
outcome of patients with RCC. Newer methods, such as DNA
ploidy analysis using flow cytometry (FCM) (Papadopoulos et al,
1995) or an image analyser (Veloso et al, 1992), have been widely
used to predict the prognosis of patients with RCC. However, this
technique appears to be unable to detect small variations in DNA
content and specific chromosomal aberrations. On the other hand,
fluorescence in situ hybridization (FISH) makes it possible to
analyse chromosomal aberrations from interphase tumour nuclei
and to detect minor cell populations of heterogeneity in chromo-
somal copy number.
With the FISH technique, various solid tumours, including
myeloma (Drach et al, 1995), gastric cancer (Gomyo et al, 1995),
breast cancer (Shackney et al, 1995), bladder cancer (Hopman et
al, 1991) and prostate cancer (Cher et al, 1995), have been studied
for numerical chromosomal aberrations. Recently, loss ofchromo-
some 3p has been shown to be a specific change for conventional
RCC, whereas gain ofchromosomes 7 and 17 and loss ofchromo-
some Y (Kovacs, 1993; Lager et al, 1995) are specific changes for
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papillary RCC. Trisomy ofchromosome 7 and monosomy ofchro-
mosomes 8, 9 and 14 also occur in RCC (Kovacs et al, 1989). In
clinical practice, loss of chromosome 14q detected by FISH was
significantly correlated with histological grade, pathological stage
and clinical outcome of RCC (Wu et al, 1996). In this study, we
used FISH with chromosome 3-, 7-, 9- and 17-specific cx-satellite
DNA probes from alcohol-fixed touch preparations of RCCs to
evaluate the relationship of respective chromosomal aberrations
with established parameters of malignancy such as histological
grade, tumour stage, venous involvement and DNA ploidy.
Moreover, we analysed how specific chromosomal aberration
was associated with tumour development and progression by
means of comparison between chromosomal aberration and
factors such as tumour cell proliferation that were necessary for
tumour development and progression.
MATERIALS AND METHODS
Samples
Twenty-one patients with RCC were treated by radical nephrectomy
at Shimane Medical University Hospital between December 1993
and February 1997. The average age of the patients was 62.5 years
(range 26-73). Tumour grade, pathological stage and tumour type
were classified according to the TNM classification (Hermanek et
al, 1987) and Fuhrman's nuclear grade (Fuhrman et al, 1982).
Tumour cell type included clear cell, granular cell and mixed cell
subtype. Touch preparation slides were made from each radical
nephrectomy specimen in the operating room. Cells on slides were
fixed in Carnoy's (methanol-acetic acid, 3:1) for 10min and air
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Table 1 Clinical data, DNA ploidy and Ki 67 expression in 21 renal cell carcinomas
Growth Venous
Case Age/sex Cell type pattern T-Stage Grade involvement DNA ploidy Ki 67 (%)
1 67/F Granular Solid 1 3 - Diploidy 5.07
2 58/F Clear Alveolar 2 1 - Diploidy 5.28
3 66/M Clear Alveolar 2 1 + Diploidy 6.13
4 70/F Clear Alveolar 2 1 - Diploidy 10.4
5 60/M Clear Alveolar 2 1 - Diploidy 6.66
6 72/M Clear Alveolar 2 1 - Diploidy 10.3
7 70/M Clear Alveolar 2 1 - Diploidy 2.61
8 70/M Clear Alveolar 2 1 - Diploidy 2.36
9 26/M Clear Alveolar 2 1 + Diploidy 6.39
10 72/M Clear Alveolar 2 1 + Diploidy 6.07
11 64/M Clear Alveolar 2 3 + Diploidy 18.5
12 71/M Clear Alveolar 3 2 + Diploidy 0.62
13 61/M Clear Alveolar 1 1 - Aneuploidy 7.35
14 61/F Clear Alveolar 2 1 - Aneuploidy 13.6
15 72/M Clear Alveolar 2 1 - Aneuploidy 3.87
16 54/M Mixed Alveolar 2 1 - Aneuploidy 5.07
17 72/M Clear Alveolar 2 3 + Aneuploidy 11.5
18 43/M Clear Alveolar 3 3 + Aneuploidy 6.04
19 54/M Clear Alveolar 3 3 + Aneuploidy 34.6
20 66/M Clear Alveolar 3 1 + Aneuploidy 6.35
21 63/F Clear Alveolar 3 4 + Aneuploidy 18.5
dried. Slides were stored at -80°C until use. The tumour tissues
were fixed in 10% buffered formalin and embedded in paraffin wax
for FCM and histological evaluation.
Chromosome-specific probes
The repetitive DNA probes for chromosomes 3, 7, 17 (alpha satel-
lite) and 9 (classic satellite) were used. Digoxigenin-labelled
probes for chromosomes 3 (D3Z1), 7 (D7Z2), 9 (D9Z1) and 17
(D17Z1) were obtained from Oncor (Gaitherburg, MD, USA).
Processing of touch preparation slides for
fluorescence in situ hybridization
The FISH procedure was performed according to the previous
study (Pinkel et al, 1986) with some modifications. The slides
were pretreated by heating in 50% glycerol/0.1 x SSC solution,
pH 7.5, at 90°C for 10 min to decondense the chromatin and to
improve hybridization efficiency (Visakorpi et al, 1994) and then
treated by proteinase K (0.2 tg ml-', Sigma Chemical, St Louis,
MO, USA) for 10 min at 37°C in a water bath. The slides were
immersed in 70% formamide/2 x SSC at 70°C for 3 min, thus
providing heat-denatured chromosomes, and were later fixed in
70% ethanol at -20°C for 2 min.
FISH
A hybridization mixture (digoxigenin-labelled DNA probes and
hybrisol VI purchased from Oncor) contained in a tube was heated
at 70°C for 6 min for denaturation of the probe. Then 30gl ofthis
mixture was dropped over the cells. Hybridization was carried out
under a coverslip in a moist chamber at 37°C for 1-2 days. Post-
hybridization washings were performed in 50% formamide/2 x
SSC at 45°C for 5 min and then washed in 2 x SSC and PN buffer
(0.1 M phosphate buffer, pH 8.0, and 0.1% NP-40) for 3 min each,
after preblock with PNM (5% Carnation milk, 0.02% sodium
Table 2 Signal numbers of chromosomes 3, 7, 9 and 17 in 21 RCCs
Chromosome % of signal numbera Range
Chromosome 3
Monosomy 37.7 +20.7*,** 2.4-85.1
Disomy 49.4 ± 14.4 13.9-71.8
Hyperdiploid 12.9+ 13.5 1.0-49.4
Chromosome 7
Monosomy 14.2 ± 13.8* 0-53.0
Disomy 62.0 ± 16.2 41.2-87.6
Hyperdiploid 24.2 + 20.2 1.0-58.5
Chromosome 9
Monosomy 25.0 ± 19.0** 4.0-72.6
Disomy 68.5 ± 17.0 27.4-90.3
Hyperdiploid 6.6 + 3.9 0-14.4
Chromosome 17
Monosomy 21.8+ 14.5* 2.1-59.0
Disomy 65.0+ 17.9 27.9-89.4
Hyperdiploid 13.2 ± 19.1 0.5-65.4
aValues are expressed as mean ± s.d. *P < 0.001, **P= 0.03
azide in PN buffer) for 10 min. FISH reactions were performed
using digoxigenin-labelled probes, then immunocytochemically
processed using FITC-conjugated anti-digoxigenin. If necessary,
immunological amplification was performed by using rabbit anti-
sheep followed by FITC-conjugated anti-rabbit.
Fluorescence signals in 200 or more non-overlapping interphase
nuclei with intact morphology were counted by two investigators
(YW and HY). Data are expressed as the mean of these counting
results. For scoring ofsignals, we used the criteria described previ-
ously (Hopman et al, 1989). Five normal renal specimens were
used to determine background levels for cells with one and more
than three signals.
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Table 3 Relationship of chromosomal aberrations with clinical parameters and DNA ploidy in 21 RCCs
Chromosome Histological grade T-stage Venous involvement DNA ploidy
G 1 (15) G 2,3,4 (6) T1+T2 (16) T3+T4 (5) - (11) + (10) Diploid (12) Aneuploid (9)
Chromosome 3
Monosomy 40.5± 20.6a 33.1 ± 21.4 41.1 ± 21.5 26.7± 14.5 39.8+ 22.3 37.4 ± 21.0 44.2+ 21.8 28.9± 16.5
Disomy 47.6 ± 15.2 52.3± 13.41 48.1 + 16.2 53.5± 5.1 48.9± 17.2 45.0± 7.9 48.2± 16.0 51.0± 12.7
Hyperdiploid 12.0±14.8 4.4±12.0 10.7±13.6 23.4± 18.5* 11.2±15.1 17.6±18.0 7.5±9.3 20.1 ± 15.4**
Chromosome 7
Monosomy 16.7 ± 16.1 10.1 ± 8.1 14.4± 15.1 13.4 ± 9.0 13.2± 11.1 19.8± 17.0 17.8± 16.3 9.4± 8.0
Disomy 62.6±16.6 60.9±16.72 62.6±17.7 60.1 ±11.5 72.3±14.9 49.9±12.6* 63.7±17.8 59.7±14.6
Hyperdiploid 20.6± 20.1 9.9± 20.5 23.4± 21.7 26.8± 16.6 14.6 ± 16.3 31.1 ± 22.0 19.7± 20.0 31.0± 18.5**
Chromosome 9
Monosomy 27.6 ± 22.5 20.8 ± 11.37 27.9 ± 20.5 15.5 ± 9.3 24.8 ± 17.9 20.1 ± 12.3 28.8 ± 20.8 19.8± 16.0
Disomy 67.2 ± 20.7 0.6 ± 9.4* 65.8 ± 18.2 76.9 ± 9.8 66.5 + 15.6 66.9 ± 16.4 64.9 ± 18.6 73.3 ± 14.4
Hyperdiploid 5.3 ± 3.7 8.7+ 3.2 6.2 ±4.3 7.7 ± 1.5 8.8 ± 6.6 13.1 ± 19.4 6.3+4.4 6.9± 3.2
Chromosome 17
Monosomy 22.5 ± 15.4 20.7 ± 14.06 22.5 ± 14.5 19.5± 16.1 25.7+ 21.5 27.1 ± 19.3 23.6± 15.8 19.3± 13.1
Disomy 66.9± 17.8 1.9± 18.81 68.3± 17.1 54.5± 18.1 64.2±22.6 53.9±22.9 71.7+ 15.1 56.0± 18.2'**
Hyperdiploid 10.6 ± 17.0 7.4+ 22.8 9.2± 15.4 26.0 ± 25.9 10.1 ± 17.8 19.0 ± 27.9 4.7± 3.1 24.5± 25.5
aMean percentage ± s.d. The numbers in parenthesis indicate the numbers of cases. *P = 0.04, **P = 0.02, ***P= 0.002.
Table 4 Relationship of chromosomal aberrations with Ki 67 expression in
21 renal cell carcinomas
Chromosome Ki 67 expression
P-value Correlation coefficient
Chromosome 3
Monosomy 0.06 -0.41
Disomy 0.30 0.23
Hyperdiploid 0.08 0.39
Chromosome 7
Monosomy 0.34 -0.22
Disomy 0.03 -0.48
Hyperdiploid 0.01 0.54
Chromosome 9
Monosomy 0.86 0.04
Disomy 0.94 -0.02
Hyperdiploid 0.56 -0.13
Chromosome 17
Monosomy 0.04 -0.46
Disomy 0.27 -0.25
Hyperdiploid 0.005 0.58
Flow cytometry
Nuclear suspensions were prepared using a modification of the
methods as described previously (Schutte et al, 1985). Paraffin
sections (40 gm) were deparaffinized with xylene, rehydrated with
graded ethanol solutions (100%, 90%, 70%, 50%) for 10 min each
and washed twice with distilled water. The tissues were then incu-
bated overnight in 3 ml of0.25% trypsin in citrate solution at 37°C
with continuous vortexing. The samples ofmechanically disaggre-
gated cells were stained with propidium iodide (PI) for DNA esti-
mation (Vindelov, 1977). Fluorescence was quantified with a
488-nm argon laser FACStar flow cytometer (Becton Dickinson,
Sunnyvale, CA, USA). A total of 2.0 x 104 nuclei were analysed
for each sample, with a flow rate of approximately 150 nuclei per
second. DNA aneuploidy was defined as a distinct peak separated
from the diploid peak of the same tumour. The DNA index was
determined as the ratio of the aneuploid mean channel number
divided by the diploid GJG, mean channel number.
Immunohistochemistry of Ki 67
Immunostaining of Ki 67 was performed using monoclonal anti-
body (NCL-Ki67-MMI; Novocastra Laboratories, Newcastle,
UK) according to the avidin-biotin immunoperoxidase method.
The sections were pretreated by microwaving them at 700 W for
5 min to retrieve the Ki 67 antigen then counterstained with 0.5%
methyl green solution. The positive ratio ofimmunostaining for Ki
67 was evaluated using the Quantitative Estrogen/Progesteron
Analysis software in the CAS 200 Image Analyser. The positive
rate of immunostaining (PR) was expressed as the mean
percentage of the tumour cells exhibiting positive staining in the
total number measured in at least 20 different fields.
Statistics
The Kruskal-Wallis test was used to examine the relationship
between histological grade, tumour stage, venous involvement,
DNA ploidy and chromosomal aberration ofchromosomes 3, 7, 9
and 17 detected by FISH. The correlation ofchromosomal aberra-
tion with Ki 67 expression was analysed statistically using a
Pearson's correlation coefficient. A level ofP < 0.05 was regarded
as statistically significant.
RESULTS
Patients (Tables 1 and 2)
In normal controls, the percentage (mean ± s.d.) ofnuclei with more
than three signals for chromosomes 3, 7, 9 and 17 were
4.7 ± 0.8%, 4.1 ± 1.3%, 3.0 ± 1.8% and 2.7 ± 1.8% respectively. The
percentage (mean ± s.d.) ofnuclei with one signal for chromosomes
British Journal ofCancer(1998) 77(11), 2003-2007 0 CancerResearch Campaign 19982006 Y Wada et al
3, 7, 9 and 17 were 3.9 ± 2.3%, 19.4 ± 20.5%, 16.1 ± 5.6% and
24.2 ± 7.3% respectively. The clinical parameters, DNA ploidy and
Ki 67 expression of21 RCCs are shown in Table 1. The positive rate
of Ki 67 expression ranged from 0.62% to 34.6% (mean 8.9). Table
2 contains mean percentage ofsignal number forchromosomes 3, 7,
9 and 17 detected by FISH. Mean percentages of loss of chromo-
some 3 were significantly higher than those of chromosomes 7, 9
and 17 (P < 0.001, P = 0.03 and P < 0.001 respectively).
Relationship of chromosomal aberrations detected by
FISH with clinical parameters and DNA ploidy status
(Tables 3 and 4)
The incidence of hyperdiploid aberration of chromosome 9 was
significantly correlated with histological grade (P = 0.04) (Table
3). Hyperdiploid aberration of chromosomes 3 and 17 was seen
more frequently in RCCs with advanced stage than those with low
stage (P = 0.04, P = 0.04 respectively). The incidence ofdisomy of
chromosome 7 was significantly lower in tumours exhibiting
venous involvement than those not exhibiting venous involvement
(P = 0.04). The remaining chromosomal aberrations were not
interrelated with venous involvement. The incidence of hyper-
diploid aberration of chromosomes 3, 7 and 17 was significantly
lower in tumours with DNA diploidy than in those with DNA
aneuploidy (P = 0.02, P = 0.02, P = 0.002 respectively). However,
in chromosome 9 there was no correlation ofchromosomal aberra-
tion with DNA ploidy.
Relationship of chromosomal aberrations detected by
FISH with Ki 67 expression (Table 4)
Ki 67 expression was closely related with hyperdiploid aberration
of chromosomes 7 and 17 (P = 0.01, P = 0.005, r = 0.58, r = 0.54
respectively) and bore a reciprocal relation to disomy of chromo-
some 7 and monosomy of chromosome 17 (P = 0.03, P = 0.04,
r = -0.48, r = -0.46 respectively).
DISCUSSION
Recently, cytogenetic studies have revealed aberration of chromo-
some 7 to be a common event in RCC (Presti et al, 1991; Meloni et
al, 1992). Beck et al (1995) reported that gain of chromosome 7
was found in 61% of RCC patients with DNA aneuploidy using
FISH. However, the current results documenting a positive correla-
tion between hyperdiploid aberration of chromosome 7 and DNA
aneuploidy, as well as the correlation between aberration for chro-
mosome 7 and venous involvement, appeared to suggest that gain
and loss of chromosome 7 was significantly associated with a
progress of the tumour invasion into vessels. Moreover, aberration
ofchromosome 7 was correlated with Ki 67 expression. Therefore,
aberration of chromosome 7 appears to result from the process of
gaining the metastatic potential as well as invading potential, which
is a complicated phenomenon involving tumour cell proliferation.
In conventional RCC, the loss of chromosome 3p has been
reported to be a frequent event (Meloni et al, 1992; Kovacs et al,
1989). In this study, loss of chromosome 3 was frequently
observed and the mean percentage in loss of chromosome 3 was
significantly higher than that observed in chromosomes 7, 9 and
17, which seems to be in agreement with the previous report
described by Wu et al (1996), in which the loss ofchromosome 3p
was found in 90% ofpatients with RCC using the FISH technique.
Therefore, the loss of chromosome 3 might represent a biological
characteristic of RCC. However, the incidence of loss of chromo-
some 3 had no correlation with clinical parameters such as Ki 67
expression in this study. These findings suggested that the effect of
loss ofchromosome 3 on tumour development of RCC might be a
rather early event. On the other hand, although there have been
few reports regarding gain of chromosome 3 in RCC, our
study demonstrated that gain of chromosome 3 was significantly
correlated with advanced stage as well as DNA aneuploidy.
Therefore, switching off the balance between gain and loss of
chromosome 3 appeared to be significantly attributed to tumour
development in RCC.
It has been reported that gain of chromosome 17 is a frequent
cytogenic event in papillary RCC (Kovacs, 1993; Lager et al,
1995). Gain of chromosome 17 was significantly correlated with
tumour stage. In addition, a significant correlation was noted
between monosomy or hyperdiploid aberration of chromosomes
17 and Ki 67 expression in our study. p53 has been implicated as
one ofthe tumour-suppressor genes and is located on chromosome
17p (Finlay et al, 1989). Mutation of the p53 gene frequently
occurs in relation to neoplastic transformation is one of the steps
involving malignant transformation and represents a malignant
proliferation (Hollstein et al, 1991). Keeping this fact in mind, it
might be quite reasonable that chromosomal gain or loss caused by
inactivation of those genes is correlated with Ki 67 expression.
Considering that the incidence of chromosome 17 abnormalities
was increased along with tumour proliferation as evaluated by Ki
67 expression, our results seem to indicate that the aberration of
chromosome 17 is a useful biological parameter for predicting
disease progression.
In bladder tumours, as far as chromosome 9 was concerned,
Yokogi et al (1996) reported that loss of chromosome 9 was
frequently observed. In this study, a significant correlation was
noted between hyperdiploid aberration of chromosome 9 and
nuclear grade. Therefore, gain of chromosome 9, but not loss of
chromosome 9, might be associated with tumour malignant behav-
iour. Further study was required to elucidate the relationship
between hyperdiploid aberration of chromosome 9 and tumour
progression in RCC.
The significance of tumour stage as a prognostic indicator for
RCC is recognized (Nurmi, 1984), whereas it is controversial for a
grading system to be reliable regarding prognostic relevance
because of the interobserver variation (Fuhrman et al, 1982;
Bretheau et al, 1995; Lanigan, 1995). However, our data demon-
strated that specific chromosomal aberration detected by FISH
was correlated with tumour stage and nuclear grade. These results
might suggest that specific chromosomal aberrations are possible
prognostic factors for RCC.
In summary, the preliminary results of our study revealed that
the chromosomal aberrations as assessed by the FISH technique
appears to provide a new clinical insight into determination of the
biological potential of RCCs, considering that (1) chromosomal
aberrations as detected by FISH were interrelated with clinico-
pathological features and (2) some were associated with Ki 67
expression. In particular, it is suggested that gain ofa chromosome
might be clinically relevant for predicting the clinical outcome of
patients with RCC. Multivariate survival analysis including a
larger series of RCCs would clarify the prognostic significance of
chromosomal aberration as detected by FISH.
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